鶹ý

Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 26-Jan-2016 9:05 AM EST
Scientists Identify Potential “Guardian” Against Neurodegeneration
Van Andel Institute

Stopping disruptions in cellular “trash removal” brought on by errors in molecular marks on DNA may guard against neurodegenerative diseases like Parkinson’s.

Released: 30-Mar-2016 2:00 PM EDT
New Compounds May Aid in Development of Targeted Therapies for a Rare Pediatric Cancer
Van Andel Institute

Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.

Released: 28-Jul-2016 8:00 AM EDT
Indicators of Parkinson’s Disease Risk Found in Unexpected Places
Van Andel Institute

Clues that point toward new risk mechanisms for developing Parkinson’s disease are hiding in some unusual spots, according to a study published today in Scientific Reports.

Released: 8-Aug-2016 3:25 PM EDT
New Model Recreates Early Spread of Parkinson’s Disease in the Brain
Van Andel Institute

They’re two of the biggest mysteries in Parkinson’s disease research—where does the disease start? And how can it be stopped early in the process?

Released: 9-Aug-2016 3:05 PM EDT
Reduced Activity of an Important Enzyme Identified Among Suicidal Patients
Van Andel Institute

It is known that people who have attempted suicide have ongoing inflammation in their blood and spinal fluid. Now, a collaborative study from research teams in Sweden, the US and Australia published in Translational Psychiatry shows that suicidal patients have a reduced activity of an enzyme that regulates inflammation and its byproducts.

Released: 29-Aug-2016 11:05 AM EDT
Vitamin C May Boost Effectiveness of Acute Myeloid Leukemia Treatment
Van Andel Institute

A simple adjustment to patients’ therapeutic regimen may improve the effectiveness of the standard epigenetic treatment for myeloid dysplastic syndrome (MDS) and acute myeloid leukemia (AML).

Released: 8-Sep-2016 10:05 AM EDT
Diabetes Drug Focus of New Clinical Trial for Parkinson’s Disease
Van Andel Institute

Type II diabetes and Parkinson’s disease may not appear to have much in common but a look below the surface reveals important molecular similarities that provide a potential target for fighting Parkinson’s.

Released: 3-Nov-2016 2:00 PM EDT
New Computational Tool May Speed Drug Discovery
Van Andel Institute

A new computational tool called fABMACS is helping scientists see beyond static images of proteins to more efficiently understand how these molecules function, which could ultimately speed up the drug discovery process.

7-Dec-2016 2:00 PM EST
Diabetes Drug Slows Experimental Parkinson’s Disease Progression, Human Trials to Begin Next Year
Van Andel Institute

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world’s first treatment to impede the progression of Parkinson’s disease following publication of research findings today in the journal Science Translational Medicine.

4-Jan-2017 1:00 PM EST
Comprehensive Study of Esophageal Cancer Reveals Several Molecular Subtypes, Provides New Insight Into Increasingly Prevalent Disease
Van Andel Institute

A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ markedly in their molecular characteristics and should be considered separate diseases.


close
1.7955